QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership
07 Marzo 2024 - 7:30AM
Business Wire
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company
engaged in research, development, and commercialization of
innovative body imaging systems, is pleased to announce the first
commercial sale of a QTI Breast Acoustic CT™ System to True Health
Center for Functional Medicine. QTI’s inaugural customer was born
as a result of the collaboration with our previously announced
strategic distribution partner and represents the business model to
be deployed by the company.
The QTI Breast Acoustic CT™ System, featuring the trademarked
Breast ACT™ technology, is an advancement in breast imaging. Unlike
traditional mammography, this state-of-the-art system offers
numerous key advantages to a patient-centric approach. By
eliminating uncomfortable breast compression, radiation exposure,
and the need for contrast agents or injections, this innovative
system prioritizes patient comfort and safety while delivering
high-quality, high-resolution 3D images. Also, in overcoming the
limitations of traditional methods, the QTI system ensures
consistent and reproducible image quality for patients with dense
breast tissue or implants, backed by rigorous validation from the
National Institutes of Health. Lastly, this NIH-funded technology
represents a significant advancement in healthcare imaging, setting
a new standard in breast imaging excellence.
“The QTI Breast Acoustic CT™ System represents a leap forward in
patient-centric breast imaging. By harnessing the power of our
advanced technology and eliminating the discomfort associated with
traditional methods, we're redefining the standard of care and
empowering patients with a safer, more comfortable imaging
experience,” said Nasser Pirshafiey, Chief Product Officer at QTI.
“This partnership serves as a testament to the advancements in
breast imaging technology and as testimonial of our team’s
commitment to the commercialization of QTI’s advanced
products.”
“As the inaugural customer of QTI’s partnership, True Health
Center for Functional Medicine is proud to lead the way in
providing our patients with the latest advancements in breast
imaging technology. The QTI Breast Acoustic CT™ System's
patient-centric approach aligns perfectly with our commitment to
delivering exceptional care while prioritizing comfort and safety,”
stated Dr. Kristine Burke at True Health Center for Functional
Medicine.
This strategic partnership marks a significant achievement for
QTI and serves as a testament to the advancements in breast imaging
technology.
About QT Imaging Holdings, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical
device company engaged in research, development, and
commercialization of innovative body imaging systems using low
frequency sound waves. QT Imaging Holdings, Inc. strives to improve
global health outcomes. Its strategy is predicated upon the fact
that medical imaging is critical to the detection, diagnosis, and
treatment of disease and that it should be safe, affordable,
accessible, and centered on the patient’s experience. For more
information on QT Imaging Holdings, Inc., please visit the
company’s website at www.qtimaging.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Such statements contain words such as “will,” and
“expect,” or the negative thereof or comparable terminology, and
include (without limitation) statements regarding the strategic
partnership between QT Imaging Holdings and our previously
disclosed distribution partner, the QTI Breast Acoustic CT™ System,
plans for QT Imaging Holdings, new product development and
introduction, and product sales growth and projected revenues.
Forward-looking statements involve certain risks and uncertainties,
and actual results may differ materially from those discussed in
any such statement. These risks include, but are not limited to:
the ability of the parties to sell and deploy the QTI Breast
Acoustic CT™ System, the ability to extend product offerings into
new areas or products, the ability to commercialize technology,
unexpected occurrences that deter the full documentation and “bring
to market” plan for products, trends and fluctuations in the
industry, changes in demand and purchasing volume of customers,
unpredictability of suppliers, the ability to attract and retain
qualified personnel and the ability to move product sales to
production levels. Additional factors that could cause actual
results to differ are discussed under the heading “Risk Factors”
and in other sections of QT Imaging’s (and its predecessor,
GigCapital5, Inc.) filings with the SEC, and in its other current
and periodic reports filed or furnished from time to time with the
SEC. All forward-looking statements in this press release are made
as of the date hereof, based on information available to QT Imaging
Holdings as of the date hereof, and QT Imaging Holdings assumes no
obligation to update any forward-looking statement.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240307728835/en/
For media inquiries, please contact: Stas Budagov Chief
Financial Officer stas.budagov@qtimaging.com
QT Imaging (NASDAQ:QTI)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
QT Imaging (NASDAQ:QTI)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024